CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Open-market sale Chief Operating Officer sold 9,939 shares at $7.40 ($73,549)
- 4 Open-market sale See Remarks sold 1,290 shares at $9.41 ($12,139)
- 4 Open-market sale Chief Business Officer sold 1,261 shares at $9.41 ($11,866)
- 4 Open-market sale Chief Operating Officer sold 2,672 shares at $9.41 ($25,144)
- 4 Open-market sale See Remarks sold 12,032 shares at $9.41 ($113,221)
- 4 Open-market sale Chief Scientific Officer sold 1,436 shares at $9.41 ($13,513)
- 4 Open-market sale Chief Medical Officer sold 1,707 shares at $10.41 ($17,770)
- 4 Open-market sale See Remarks sold 1,397 shares at $10.41 ($14,543)
- 4 Planned sale Chief Business Officer sold 1,266 shares at $10.41 ($13,179)
- 4 Open-market sale Chief Operating Officer sold 1,635 shares at $10.41 ($17,020)
- 4 Open-market sale See Remarks sold 7,672 shares at $10.41 ($79,866)
- 4 Open-market sale Chief Scientific Officer sold 1,484 shares at $10.41 ($15,448)
- 4 Open-market sale See Remarks sold 51,390 shares at an average $12.71 ($653,178)
- 4 Planned sale See Remarks sold 2,259 shares at an average $12.68 ($28,649)
- 4 Open-market sale Chief Operating Officer sold 1,625 shares at $12.43 ($20,199)
- 4 Open-market sale Chief Medical Officer sold 1,698 shares at $12.43 ($21,106)
- 4 Open-market sale Chief Scientific Officer sold 1,475 shares at $12.43 ($18,334)
- 4 Open-market sale See Remarks sold 325,330 shares at an average $12.90 ($4,195,797)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 19 · 365 filings